
IMTX
Healthcare · Biotechnology · $973.0M market cap
$6.39-0.13 (-2.0%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +0.2% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | Before the open | -0.49 | -0.58 | -18.4% |
| Aug 18, 2026 | Before the open | -0.43 | -0.53 | -23.3% |
| May 12, 2026 | Before the open | -0.44 | -0.51 | -15.9% |
| Mar 25, 2026 | Time not confirmed | -0.41 | -0.34 | +18.1% |
| Nov 17, 2025 | Before the open | -0.45 | -0.49 | -8.9% |
| Aug 13, 2025 | Before the open | -0.36 | -0.68 | -88.9% |
| May 13, 2025 | Before the open | -0.33 | -0.37 | -12.1% |
| Mar 19, 2025 | Before the open | -0.34 | 0.45 | +234.3% |
| Nov 18, 2024 | Before the open | -0.28 | -0.08 | +71.4% |
| Aug 13, 2024 | Before the open | -0.31 | -0.19 | +38.7% |
| May 14, 2024 | Before the open | -0.22 | -0.03 | +86.4% |
| Mar 21, 2024 | Before the open | -0.32 | -0.30 | +6.3% |
| Nov 14, 2023 | Before the open | -0.39 |
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products…
| -0.34 |
| +12.8% |
| Aug 17, 2023 | Before the open | -0.27 | -0.35 | -29.6% |
| May 16, 2023 | Before the open | -0.30 | -0.28 | +6.7% |
| Mar 21, 2023 | Before the open | -0.17 | -0.23 | -35.3% |
| Nov 17, 2022 | Before the open | -0.44 | -0.33 | +25.0% |
| Aug 9, 2022 | Before the open | -0.06 | -0.22 | -266.7% |
| Jun 2, 2022 | Before the open | 1.92 | 1.45 | -24.5% |
| Mar 23, 2022 | Before the open | 0.20 | -0.26 | -230.0% |
| Nov 16, 2021 | Before the open | -0.34 | -0.49 | -44.1% |
| Aug 10, 2021 | Before the open | -0.39 | -0.45 | -15.4% |
| May 18, 2021 | Before the open | -0.40 | -0.41 | -2.5% |
| Mar 30, 2021 | Before the open | -1.22 | -0.47 | +61.5% |
| Dec 2, 2020 | Before the open | -0.29 | -0.47 | -62.1% |
| Sep 3, 2020 | Before the open | -0.16 | -0.24 | -50.0% |
| Jun 8, 2020 | After the close | -7.14 | -0.18 | +97.5% |
| Mar 6, 2020 | After the close | 0.00 | 0.02 | — |
| Nov 13, 2019 | Time not confirmed | — | 0.03 | — |
| Aug 12, 2019 | Time not confirmed | — | 0.05 | — |
| May 13, 2019 | Time not confirmed | — | 0.04 | — |